BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MitoCell readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MitoCell\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05094011-1601@assetmemo.bio
DTSTAMP:20261121T004448Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:MitoCell: Phase 1 readout est. (NCT05094011)
DESCRIPTION:MitoCell\, phase 1\, Parkinson's Disease.\nStudy: Evaluating Sa
 fety\, Tolerability\, and Efficacy of Autologous MitoCell Transplantation 
 in Subjects With Idiopathic Parkinson's Disease\nEstimated primary complet
 ion: 30 September 2027. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/mitocell#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT05094011
URL:https://assetmemo.bio/drug/mitocell#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
